Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation (Peripheral blood S100 mRNAs and metabolic syndrome).
暂无分享,去创建一个
T. Funahashi | Y. Matsuzawa | I. Shimomura | H. Nishizawa | N. Maeda | K. Matsubara | N. Komura | Y. Fujishima | Seiji Nakamura | Masaya Yamaoka | Susumu Kashine | Yasuhiko Nakagawa | R. Sekimoto | A. Hirata | Yu Tsushima | Takuya Mori | Kana Inoue | Keisuke Matsuda
[1] T. Funahashi,et al. A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells , 2012, PloS one.
[2] T. Funahashi,et al. High serum S100A8/A9 levels and high cardiovascular complication rate in type 2 diabetics with ultrasonographic low carotid plaque density. , 2012, Diabetes research and clinical practice.
[3] T. Funahashi,et al. High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice. , 2012, Biochemical and biophysical research communications.
[4] J. Olefsky,et al. The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.
[5] S. Kihara,et al. Dynamic Changes of Adiponectin and S100A8 Levels by the Selective Peroxisome Proliferator–Activated Receptor-&ggr; Agonist Rivoglitazone , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[6] S. Tangye,et al. Inflammatory Mechanisms in Obesity , 2013 .
[7] Gene Kim,et al. Vascular Remodeling and Arterial Calcification Are Directly Mediated by S100A12 (EN-RAGE) in Chronic Kidney Disease , 2011, American Journal of Nephrology.
[8] T. Funahashi,et al. One-Year Reductions in Body Weight and Blood Pressure, but Not in Visceral Fat Accumulation and Adiponectin, Improve Urinary Albumin-to-Creatinine Ratio in Middle-Aged Japanese Men , 2010, Diabetes Care.
[9] K. Croce. S100A8/A9 Complex , 2010 .
[10] A. Bahl,et al. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. , 2009, Atherosclerosis.
[11] B. Pedersen,et al. Calprotectin — A Novel Marker of Obesity , 2009, PloS one.
[12] M. Raftery,et al. Oxidative modifications of S100 proteins: functional regulation by redox , 2009, Journal of leukocyte biology.
[13] C. Heizmann,et al. Binding of S100 proteins to RAGE: an update. , 2009, Biochimica et biophysica acta.
[14] Y. Mori,et al. Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis , 2008, American Journal of Nephrology.
[15] W. Nacken,et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock , 2007, Nature Medicine.
[16] E. Ferrannini,et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. , 2006, The Journal of clinical endocrinology and metabolism.
[17] P. Libby,et al. Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006, Circulation.
[18] Kunihiko Kobayashi,et al. Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease , 2005, European Journal of Pediatrics.
[19] Makoto Nishida,et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. , 2005, Diabetes care.
[20] Y. Mori,et al. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.
[21] J. Flier. Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.
[22] J. Fernández-Real,et al. Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight Loss , 2011, Molecular medicine.
[23] P. Libby,et al. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. , 2008, American heart journal.
[24] Y. Matsuzawa. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.